Device Trial Radar · NCT07217392
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jul 24, 2025
Primary completion
Apr 30, 2027
Study completion Apr 30, 2027
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Oct 16, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6 months post-implant.
Conditions
- Bradycardia
- Right Ventricular Pacing
- Heart Failure
- Atrial Fibrillation (AF)
- Cardiac Disease
- Left Bundle Branch Area Pacing
- Conduction System Pacing
Interventions
LBBAP leadDevice
The lead is bipolar, steroid-eluting, active fixation, MR Conditional, implantable pacing leads that can be placed in the right atrium, right ventricle, or left bundle branch area for pacing and sensing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Infection RateTime frame: 0-6 months
- Perforation RateTime frame: 0-6 months
- Malfunction RateTime frame: 0-6 months
6 more outcomes with a free account
Locations
15 sites in 9 countries. Site status is shown where the registry gives one.
Instituto Nacional de Cardiologia (INC)
Rio de Janeiro, Rio de Janeiro, Brazil · Not yet recruiting
Instituto do Coracao (InCor) - HCFMUSP
São Paulo, São Paulo, Brazil · Not yet recruiting
Hopital d'adulte de la Timone
Marseille, Alpes, France · Recruiting
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.